Get started
Author

David E. Marinier

Clinical Utility of Autopsy after Hematopoietic Stem Cell Transplantation
2007 · Craig C. Hofmeister, David E. Marinier, et al. · Transplantation and Cellular Therapy · 16
PDF
Refractory cytopenias with unilineage dysplasia: a retrospective analysis of refractory neutropenia and refractory thrombocytopenia
2010 · David E. Marinier, Hector Mesa, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Immune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer
2022 · Yacki Hayashi-Tanner, Peter J. Polewski, et al. · Journal of Geriatric Oncology · 9
Primary CNS Leiomyosarcoma in an Immunocompetent Patient
2016 · Peter J. Polewski, Angela L. Smith, et al. · Journal of Oncology Practice · 8
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III–IV melanoma in phase III trial E1609
2022 · Laurie E. McLouth, Yue Zheng, et al. · Quality of Life Research · 6
Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
2018 · DIPESH UPRETY, AMIR BISTA, et al. · Anticancer Research · 3
PDF
Utility of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in hematopoietic stem cell transplantation (HSCT).
2017 · Patricia B. Mumby, Todd Doyle, et al. · Journal of Clinical Oncology · 3
Durable Response After 2 Doses of Pembrolizumab in a Patient With Non–Small-Cell Lung Cancer With an Isolated Brain Metastasis
2019 · Dipesh Uprety, Lubina Arjyal, et al. · Clinical Lung Cancer · 1
Training fellows in genomic oncology: A pilot team-based workshop.
2026 · Lauren O'Loughlin, Keerthi Gogineni, et al. · Journal of Clinical Oncology
Incidence of uveal melanoma surveillance and related outcomes in the immunotherapy era in a rural healthcare system.
2026 · Jake Anthony Deviley, Garrett Weber, et al. · Journal of Clinical Oncology
PDF
Utilization of germline genetic testing in prostate, pancreatic, and ovarian cancer in a rural setting.
2026 · Sean O'Neil, Miranda Ruben, et al. · Journal of Clinical Oncology
Immune related adverse events: Timing, identification patterns, and impact on survival.
2024 · Jake Anthony Deviley, Yacki Hayashi-Tanner, et al. · Journal of Clinical Oncology
Evaluation of immune related adverse events following extended interval dosing of immune checkpoint inhibitors.
2023 · Jake Anthony Deviley, Yacki Hayashi-Tanner, et al. · Journal of Clinical Oncology
Surgery versus radiation therapy outcomes in patients with clinical stage 0 non-small cell lung cancer.
2021 · Swapna Narayana, Attila J. Kovacs, et al. · Journal of Clinical Oncology
Immune checkpoint inhibitor toxicity and associated outcomes in a geriatric population.
2020 · Peter James Polewski, Yacki Hayashi-Tanner, et al. · Journal of Clinical Oncology
Role of adjuvant chemotherapy in patients with pathological stage I NSCLC with high-risk features.
2020 · Lubina Arjyal, Dipesh Uprety, et al. · Journal of Clinical Oncology
PACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non–Small Cell Lung Cancer
2018 · Dipesh Uprety, David E. Marinier · Journal of the National Comprehensive Cancer Network
PDF
The role of cytoreductive nephrectomy in elderly patients with metastatic renal cell carcinoma in an era of targeted therapy.
2017 · Dipesh Uprety, Amir Bista, et al. · Journal of Clinical Oncology
Germ-Line and Somatic Mutations in Familial Myeloproliferative Neoplasms (MPNs). a Pilot Study
2014 · Sucha Nand, Manuel O. Diaz, et al. · Blood
Works count: 19
Citation count: 57
H-index: 5
I10-index: 2
Year
Topic
Type